Cost-Effectiveness Analysis of National Smoking Cessation Service Among Chronic Obstructive Pulmonary Disease (COPD) Patients in Thailand

Author(s)

Prasitwarachot R1, Wattanasirichaigoon S2, Rungruanghiranya S3, Thongphiew A4, Thavorn K5, Chaiyakunapruk N1
1University of Utah, Salt Lake City, UT, USA, 2Thai Health Promotion Alliance Against Tobacco, Bangkok, Thailand, 3Srinakharinwirot University Ongkarak, Nakornnayok, Thailand, 4Paolo Hospital Phaholayothin, Bangkok, Thailand, 5Ottawa Hospital Research Institute, Ottawa, ON, Canada

OBJECTIVES: Smoking cessation interventions lower the risks of serious health problems and mortality and save the health system money. The national, multidisciplinary smoking cessation clinics have been founded in Thailand since 2010; however, their cost-effectiveness for patients with Chronic Obstructive Pulmonary Disease (COPD) has never been formally evaluated. This study aimed to assess the cost-effectiveness of these multidisciplinary clinics compared to usual care among patients with COPD in Thailand from a societal perspective.

METHODS: We conducted a cost-utility analysis and developed a Markov model encompassing six-health states to simulate lifetime costs and quality-adjusted life years (QALYs) of each smoking cessation intervention over the patient lifetime. The model also included two sub-models for current and former smokers. We derived the effectiveness of the smoking cessation clinics from a multicenter, longitudinal study of smoking cessation services across Thailand. We sought the natural quit rate, transition probabilities, health utility and cost data from the published literature. All future costs and outcomes were discounted at an annual rate of 3%. A series of sensitivity analyses was performed.

RESULTS: Compared to usual care, the national, multidisciplinary smoking cessation clinics were associated with higher costs and improved QALYs, with an ICER of 46,623.37 THB/QALY (1,469.19 US$/QALY). The efficacy of the national smoking cessation services was a key driver of the cost-effectiveness results. Results from the probabilistic sensitivity analysis showed the probability that the clinics are cost-effective at a willingness-to-pay (WTP) threshold of 160,000 THB (50,41.91 US$) was 97.7%.

CONCLUSIONS: The national, multidisciplinary smoking cessation clinics were cost-effective at the Thai WTP threshold of 160,000 THB/QALY due to their ability to reduce future smoking-related morbidity and mortality among COPD patients. Our results could assist health policy decision-makers in allocating resources to support smoking cessation services in Thailand.

Conference/Value in Health Info

2022-05, ISPOR 2022, Washington, DC, USA

Value in Health, Volume 25, Issue 6, S1 (June 2022)

Code

EE277

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×